Nerio Therapeutics, Inc. — Form D
Nerio Therapeutics, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-08. The offering totals $10.0M, of which $3.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-10-08
- Form: D
- Accession: 0001842455-21-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $3.5M
- Remaining: $6.5M
- Investors: 5
- Date of first sale: 2021-08-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-416368
Issuer
- Name: Nerio Therapeutics, Inc.
- CIK: 0001817835
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 11099 N. TORREY PINES ROAD, STE. 290, LA JOLLA, CA, 92037
- Phone: 858-750-4700
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Stefan J Heller | Director | La Jolla, CA |
| Jay J Lichter, Ph.D. | Director | La Jolla, CA |
| Sanford J Madigan, Ph.D. | Director | La Jolla, CA |
| Tighe J Reardon | Director | La Jolla, CA |
| Sanford J Madigan, Ph.D. | Executive Officer | La Jolla, CA |
| Tighe J Reardon | Executive Officer | La Jolla, CA |
Other filings by this issuer (1)
More